Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-7,283
Closed -$833K 151
2024
Q3
$833K Buy
7,283
+36
+0.5% +$4.28K 0.36% 55
2024
Q2
$897K Hold
7,247
0.41% 51
2024
Q1
$918K Buy
7,247
+61
+0.8% +$7.52K 0.43% 52
2023
Q4
$868K Buy
7,186
+4
+0.1% +$415 0.36% 54
2023
Q3
$744K Sell
7,182
-105
-1% -$11.3K 0.32% 57
2023
Q2
$792K Buy
+7,287
New +$827K 0.32% 59
2023
Q1
Sell
-7,177
Closed -$824K 106
2022
Q4
$824K Sell
7,177
-600
-8% -$61.3K 0.43% 46
2022
Q3
$759K Buy
7,777
+2
+0% +$179 0.41% 51
2022
Q2
$727K Buy
7,775
+2
+0% +$177 0.41% 53
2022
Q1
$666K Buy
+7,773
New +$613K 0.33% 60

Other funds holding MRK

GGM Wealth Advisors's MRK Position: Q4 2024 in Review

GGM Wealth Advisors sold out of Merck (MRK) in Q4 2024, closing a stake of 7,283 shares — an estimated $833K sold.

GGM Wealth Advisors first reported a position in MRK in Q1 2022 and held it in 10 quarters. The position peaked at $918K in Q1 2024. 3,608 funds tracked by Wall St. Rank hold MRK as of Q4 2024.

  • GGM Wealth Advisors reported no remaining Merck position as of Q4 2024 after selling out during the quarter.
  • GGM Wealth Advisors sold 7,283 Merck shares in Q4 2024, an estimated $833K.
  • GGM Wealth Advisors first reported a position in Merck in Q1 2022 and held it in 10 quarters.
  • GGM Wealth Advisors's Merck position peaked at $918K in Q1 2024.
  • 3,608 funds tracked by Wall St. Rank held Merck as of Q4 2024.

Based on GGM Wealth Advisors's 13F filing for Q4 2024, filed 15 Jan 2025.